A rare clinical phenotypeWhen used in reference to myelin oligodendrocyte glycoproten antibody disease (MOGAD), indicates the particular presentation or combination of symptoms an individual experiences based on the part of the central nervous system affected by MOGAD. of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease , which usually begins with seizuresA sudden, temporary disturbance in brain activity that causes changes in behavior, movement, sensation, or consciousness, headaches, and fever. Sometimes there is only one-sided cerebral cortical inflammationA process of the immune system that involves chemicals released by immune cells (i.e. white blood cells) inducing localized heat, swelling, redness, and pain to an area that occurs when tissue becomes damaged or infected from a pathogen, and usually results in the desctruction and removal of the pathogen and/or healing to the tissue. In the case of myelin oligodendrocyte glycoprotein antibody disease (MOGAD), inflammation is the result of the incorrect targeting of the myelin oligodendrocyte glycoprotein (MOG) by the immune system, resulting in damage to myelin sheaths. without any white matter inflammationA process of the immune system that involves chemicals released by immune cells (i.e. white blood cells) inducing localized heat, swelling, redness, and pain to an area that occurs when tissue becomes damaged or infected from a pathogen, and usually results in the desctruction and removal of the pathogen and/or healing to the tissue. In the case of myelin oligodendrocyte glycoprotein antibody disease (MOGAD), inflammation is the result of the incorrect targeting of the myelin oligodendrocyte glycoprotein (MOG) by the immune system, resulting in damage to myelin sheaths.. MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease patients who experience this phenotypeWhen used in reference to myelin oligodendrocyte glycoproten antibody disease (MOGAD), indicates the particular presentation or combination of symptoms an individual experiences based on the part of the central nervous system affected by MOGAD. are often misdiagnosed with viral encephalitisA disease in which inflammation of brain tissue caused by an infection or an autoimmune response results in swelling and damage. When caused by an autoimmune disease, sometimes called Autoimmune Encephalitis., stroke or infection.
Cerebral coritcal encephalitis (CCE)
Related Posts
Eight Years Old and Running for Her Brother
When Aria laced up her trainers for the AJ Bell Great Manchester Run, she wasn’t just racing — she was advocating for her twin brother
Global Leaders in MOGAD Research Convened May 14-16, 2026
Leading international clinicians, researchers, advocates, and industry collaborators gathered in Cambridge, Massachusetts, for two major back-to-back MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease meetings focused on research priorities, clinical trials, therapeutic
The State of MOGAD Science: Research, Treatments & What’s Next
The State of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Science: What We Learned Together This MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Awareness Month, we came together with the Siegel Rare NeuroimmuneA term that refers to the components of the immune system that acts in and affects the central nervous system. Association (SRNA) to host
